Skip to main content
Aggregate response benefit in skin clearance and itch reduction favor upadacitinib over dupilumab in AD
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Aggregate response benefit in skin clearance and itch reduction favor upadacitinib over dupilumab in AD
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Atopic Dermatitis
0
1
Biologic Therapy
0
0.55
Pruritus
0
0.19
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
1
Allergy & Clinical Immunology
0
0.94
Pediatrics
0
0.6
Pharmacist
0
0.35
Edit Tags